ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2025
Endoscopic Sleeve Gastroplasty is an Effective Treatment for Obesity in a Veteran With Metabolic and Psychiatric Comorbidities.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity is a chronic disease associated with several metabolic comorbidities. Weight loss interventions, such as bariatric surgery and endoscopic procedures like endoscopic sleeve gastroplasty (ESG), are known to improve obesity-related health conditions. However, there is limited data on the impact of endoscopic procedures on psychiatric disorders. Our report aims to describe the clinical course of a veteran with psychiatric comorbidities that prevented him from proceeding with bariatric surgery, and ultimately underwent an ESG. Case Presentation: A 59-year-old male veteran with severe obesity had limited exercise capability and poor quality of life due to a large ventral hernia. The patient's dietary, lifestyle modification, and medication-assisted weight loss attempts were unsuccessful. A planned weight loss surgery was canceled due to anxiety and a panic attack. He underwent ESG with a successful total body weight loss of 16.7% at 12 months. Subsequent improvement in metabolic and psychiatric comorbidities ultimately enabled the patient to undergo ventral hernia repair, which significantly improved his quality of life. Conclusions: This report demonstrates that ESG may be an option for weight loss in patients with psychiatric comorbidities and can lead to significant clinical improvement in multiple obesity-associated comorbidities. This case further highlights the value of endoscopic procedures as alternatives to bariatric surgery in select cases when lifestyle changes and medications have not been effective, and surgery may not be a viable option.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.